Acute bronchitis
Evidence
This page contains a snapshot of featured content which highlights evidence addressing key clinical questions including areas of uncertainty. Please see the main topic reference list for details of all sources underpinning this topic.
Cochrane Clinical Answers
Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically focused entry point to rigorous research from Cochrane systematic reviews. They are designed to be actionable and to inform decision making at the point of care and have been added to relevant sections of the main Best Practice text.
- In adults with acute bronchitis who do not have any other underlying pulmonary disease or acute respiratory illness, what are the benefits and harms of beta2-agonists?
- How do point‐of‐care diagnostic tests for acute respiratory infection affect antibiotic prescribing behavior in primary care?
- How do communication strategies affect antibiotic prescribing behavior for acute respiratory infection in primary care?
- In people with acute bronchitis, is there randomized controlled trial evidence to support the use of antibiotics?
- What are the benefits and harms of azithromycin compared with amoxicillin or amoxicillin/clavulanic acid in people with acute lower respiratory tract infections?
Use of this content is subject to our disclaimer